Alerts will be sent to your verified email
Verify Email
FREDUN
|
Fredun Pharma
|
Kilitch Drugs(India)
|
Venus Remedies
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.53 % | 4.81 % | 8.87 % |
|
5yr Avg Net Profit Margin
|
2.89 % | 6.07 % | 6.91 % |
|
Price to Book
|
3.93 | 3.07 | 1.1 |
|
P/E
|
23.7 | 22.18 | 11.46 |
|
5yr Avg Cash Conversion Cycle
|
137.13 Days | -7.56 Days | 46.96 Days |
|
5yr Average Interest Coverage Ratio
|
2.31 | 5.07 | 396.11 |
|
5yr Avg ROCE
|
16.75 % | 8.16 % | 8.42 % |
|
5yr Avg Operating Profit Margin
|
8.32 % | 9.07 % | 10.14 % |
|
5 yr average Debt to Equity
|
0.86 | 0.14 | 0.08 |
|
5yr CAGR Net Profit
|
52.4 % | 77.02 % | -6.01 % |
|
5yr Average Return on Assets
|
3.05 % | 3.38 % | 6.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
48.93 % | 69.23 % | 41.76 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.11 % | 0.98 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Fredun Pharma
|
Kilitch Drugs(India)
|
Venus Remedies
|
|---|